Understanding the stages of primary sclerosing cholangitis
Primary Sclerosing Cholangitis (PSC) is a complex liver disease with varying stages and impacts. Learn about its progression, what to expect, and how to manage your liver health effectively with our guidance and support.

The journey of PSC: From early signs to advanced stages
Primary Sclerosing Cholangitis (PSC) is a progressive disease that causes inflammation and scarring of the bile ducts. This scarring can gradually narrow or block bile ducts, interfering with normal bile flow. Early PSC may cause few or no symptoms, even while bile-duct damage is occurring. Ongoing damage may lead to liver fibrosis and reduced liver function. Not everyone progresses at the same rate, and PSC progression varies greatly among individuals.

Common concerns and critical insights
Many individuals with PSC wonder: How quickly will my PSC progress? Will PSC always lead to cirrhosis or liver failure? How do I know what stage my PSC is in? Can treatment slow or stop the disease from progressing? Understanding that PSC progresses differently for everyone is key. Regular monitoring is essential, as PSC increases the risk of complications, including bile-duct cancer (cholangiocarcinoma). Advanced PSC can progress to cirrhosis and complications of chronic liver disease, potentially requiring a liver transplant.

Support and care at every stage
Specialized medical care can make a difference at every stage of PSC. For early stages, work with a liver specialist, keep regular appointments, and monitor liver tests and symptoms. For progressing disease, follow recommended imaging and monitoring, manage symptoms and complications, and report new or worsening symptoms promptly. If advanced disease occurs, specialized care may be needed to manage cirrhosis and other complications, including consideration of a liver transplant evaluation when appropriate. Stay informed, follow your healthcare team's recommendations, and use trusted educational and support resources, including those from The Liver Hope Foundation.